Trial Profile
Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men Following Introduction of Universal Male HPV Vaccination Program in Australia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2021
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms HYPER2
- 20 Jul 2021 Status changed from active, no longer recruiting to completed.
- 01 Jul 2019 Planned End Date changed from 1 Dec 2018 to 31 Dec 2019.
- 01 Jul 2019 Planned primary completion date changed from 1 Dec 2018 to 31 Dec 2019.